Our research revealed that RAC3 is markedly overexpressed in bladder cancer tissues and cells compared with their normal counterparts and that this overexpression is linked to the severity of malignant characteristics and an unfavorable prognosis for patients. This evidence concerns the gene RAC3 and urinary bladder cancer.